Predictive DMPK: In Silico ADME Predictions in Drug Discovery
Jane R. Kenny · Molecular Pharmaceutics · 2013
ADVERTISEMENT RETURN TO ISSUEEditorialNEXTPredictive DMPK: In Silico ADME Predictions in Drug DiscoveryJane R. Kenny*View Author Information Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, California 94080, United States*Phone: 1 650 467 6027. E-mail: [email protected]Cite this: Mol. Pharmaceutics 2013, 10, 4, 1151–1152Publication Date (Web):April 1, 2013Publication History Published online1 April 2013Published inissue 1 April 2013https://pubs.acs.org/doi/10.1021/mp400102thttps://doi.org/10.1021/mp400102teditorialACS PublicationsCopyright © 2013 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views2020Altmetric-Citations6LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (127 KB) Get e-AlertscloseSUBJECTS:Drug discovery,Pharmaceuticals,Pharmaceutics,Power Get e-Alerts